Maternal GBS vaccination for preventing group B streptococcus disease in newborns: A mini review of current evidence
International Journal of Gynecology & Obstetrics · 2024
DOI: 10.1002/ijgo.15465 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Emmanuel Kokori und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University of Ilorin, Ilorin, Nigeria. Hauptthemen laut MEDLINE: Streptococcal Infections, Streptococcal Vaccines, Streptococcus agalactiae, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Group B streptococcus (GBS) poses a significant threat to neonates, leading to morbidity and mortality. Intrapartum antibiotics, although effective, have limitations, prompting the exploration of maternal vaccination. This study reviews the current evidence for maternal GBS vaccination in the prevention of early‐onset GBS disease in newborns. A search on Google Scholar, PubMed, and Scopus identified studies assessing the impact of maternal GBS vaccination on early‐onset GBS disease. Inclusion criteria comprised English‐language clinical trials or observational studies. Data extraction included study details, immunogenicity profiles, effectiveness, safety outcomes, and relevant findings. Qualitative synthesis was employed for data analysis. Five studies meeting the inclusion criteria were reviewed. Maternal GBS vaccines demonstrated efficacy with sustained immunogenicity. Adverse events, although documented, were predominantly non‐severe. Variability in immune responses and maternal‐to‐infant antibody ratios show the need for tailored vaccination approaches. Long‐term follow up and surveillance are essential to assess persistence and identify unintended effects. Positive outcomes in vaccine efficacy support GBS vaccination integration into maternal health programs. Implementation challenges in diverse healthcare infrastructures require tailored approaches, especially in resource‐limited settings. Overcoming cultural barriers and ensuring healthcare provider awareness are crucial for successful vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Surgery, University of Ilorin, Ilorin, Nigeria.
- Department of Medicine, Siberian State Medical University, Tomsk, Siberia, Russia.
- Department of Medicine, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.
- Department of Internal Medicine, Asokoro District Hospital, Abuja, Nigeria.
- Department of Medicine, Lagos State Health Service Commission, Lagos, Nigeria.
Zitieren
APA
Kokori, E., Olatunji, G., Komolafe, R., Ogieuhi, I. J., Oyebiyi, B., Ajayi, I., Muogbo, I., Ukoaka, B., Samuel, O., & Aderinto, N. (2024). Maternal GBS vaccination for preventing group B streptococcus disease in newborns: A mini review of current evidence. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15465
Vancouver
Kokori E, Olatunji G, Komolafe R, Ogieuhi IJ, Oyebiyi B, Ajayi I, et al. Maternal GBS vaccination for preventing group B streptococcus disease in newborns: A mini review of current evidence. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15465
BibTeX
@article{Kokori2024,
author = {Kokori, Emmanuel and Olatunji, Gbolahan and Komolafe, Rosemary and Ogieuhi, Ikponmwosa Jude and Oyebiyi, Babajide and Ajayi, Irene and Muogbo, Ifeanyichukwu and Ukoaka, Bonaventure and Samuel, Owolabi and Aderinto, Nicholas},
title = {Maternal GBS vaccination for preventing group B streptococcus disease in newborns: A mini review of current evidence},
journal = {International Journal of Gynecology & Obstetrics},
year = {2024},
doi = {10.1002/ijgo.15465}
}
EUVIMED